Sort
59,101 grants matching “hypertension”
Cognitive Function in SLE (COGNITION)
$876,366Robin L Brey · University Of Texas Hlth Science Center · R01 · FY2007 · NS
Regulation of Cell Fate during Kidney Development and Disease
$876,233Roberto Ariel Gomez · University Of Virginia · P50 · FY2024 · DK
Regulation of Cell Fate during Kidney Development and Disease
$876,233Roberto Ariel Gomez · University Of Virginia · P50 · FY2023 · DK
The Study of HIV Infection in the Etiology of Lung Disease (SHIELD)
$875,872Gregory D Kirk · Johns Hopkins University · R01 · FY2011 · HL
Intersection of Material-Need Insecurities and HIV and Cardiovascular Health
$875,689Sheri Dawn Weiser · University Of California, San Francisco · R01 · FY2020 · HL
Environmental Disasters and Impacts on Health Care Systems
$875,655Roberta Proffitt Lavin · University Of New Mexico · P20 · FY2024 · NR
Mechanosensitive Channel based Pressure-Modulating Gene Therapy for Glaucoma Treatment
$875,350Adnan Ismail Dibas · Nanoscope Technologies, Llc · R44 · FY2023 · EY
Novel Device to Optimize Aerosol Drug Delivery for Pulmonary Hypertension Treatment
$875,246John E Porterfield · Bridgesource Medical Corporation · R44 · FY2024 · HL
Women's Health Study: Continued Follow-Up
$875,149Julie E Buring · Brigham And Women'S Hospital · R01 · FY2008 · HL
Maternal Lifestyles Study Phase V
$875,047Seetha Shankaran · Wayne State University · U10 · FY2007 · DA
New York State Component A: BD-STEPS II Core
$875,000Marilyn L. Browne · Center Of Environmental Health · U01 · FY2019 · DD
Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias
$874,857Wei-Qi Wei · Vanderbilt University Medical Center · R01 · FY2025 · AG
Proteomic Markers of Arteriosclerosis
$874,844Iftikhar J Kullo · Mayo Clinic Rochester · U01 · FY2008 · HL
Targeting Residual ASCVD Risk by Integrating Genetics and Clinical Data
$874,792Wei-Qi Wei · Vanderbilt University Medical Center · R01 · FY2024 · HL
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
$874,732Lauren Costella · Luna Labs Usa, Llc · R44 · FY2023 · HD
Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias
$874,542Wei-Qi Wei · Vanderbilt University Medical Center · R56 · FY2024 · AG
Mild Cognitive Impairment: Cerebrovascular Dysfunction and Exercise Training
$874,381Rong Zhang · Ut Southwestern Medical Center · R01 · FY2011 · AG
Topiramate as a Disease Altering Therapy for CSPN
$874,009A Gordon Smith · Virginia Commonwealth University · U01 · FY2020 · NS
1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
$873,890Gustavo Adolfo Heresi Davila · Cleveland Clinic Lerner Com-Cwru · UH3 · FY2025 · HL
Mediators of fatty liver disease during HIV/SIV and cART treatment
$873,771Donald L Sodora · Seattle Children'S Hospital · R01 · FY2020 · AI
Administrative Core
$873,624Andrea L Cherrington · University Of Alabama At Birmingham · P50 · FY2025 · MD
A collaborative model to improve BP control and minimize racial disparities-CCC
$873,612Barry L Carter · University Of Iowa · R01 · FY2012 · HL
S-nitrosothiol analyzer for the clinical diagnosis of cardiovascular disease mark
$873,517Michael R Pisano · Accord Biomaterials, Inc. · R44 · FY2011 · HL
Ca2+ signaling Networks in Health and Disease
$873,455Mohamed Trebak · University Of Pittsburgh At Pittsburgh · R35 · FY2025 · HL
Anthipertensive PharmacoGenomics
$873,149Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2003 · HL